MedTrace Logo

Nasogastric/Orogastric Tube Placement Confirmation in Neonates Utilizing Self-contained pH Device, a Feasibility Study

NCT06274944 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 12

Last updated 2025-01-27

No results posted yet for this study

Summary

This study is looking at using a self-contained pH device that will assist in confirming placement of a nasogastric or orogastric tube placed in the stomach of hospitalized infants.

Conditions

  • Premature Birth

Interventions

DEVICE

nasogastric tube placement pH confirmation device

Each participation will get the contents tested by the novel device and the standard of care procedure.

Sponsors & Collaborators

Principal Investigators

  • Jonathan Strutt · University of Minnesota

Eligibility

Max Age
2 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-02-12
Primary Completion
2025-01-21
Completion
2025-01-21
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06274944 on ClinicalTrials.gov